Global Stents Market by Type (Bare-metal Stents, Bioresorbable Vascular Scaffold, Drug Eluting), Mode of Delivery (Self-expandable, Balloon Expandable), Material (Metal, Polymer), End User (Hospital, Ambulatory Surgery Centers, Others) and Region (North America, Europe, Asia-pacific, Latin America, Middle East and Africa): Global Forecasts 2017 to 2027

The Global stents market was valued at US$ 8.0 Bn in 2020 is expected to reach US$ 11.3 Bn by 2027, with a growing CAGR of 4.9% during the forecast period (2021-2027).

Stents are small, mesh-like expandable tubes that are inserted into narrowed arteries in the body in order to open up vessels or arteries. Depending upon clinical condition, varieties of stents are available. Stent implantation is most commonly used in cardiac diseases like artery blockage, atherosclerosis, etc. Stents are also used in expanding oesophagus to allow the passage of edible items to the patients with oesophageal cancer. Stents are also used in ureter and bile. Stents are mostly made up of metal, polymers and bioabsorbable materials. These materials do not cause any harm to the body and stents can be kept for years and years. Increase in technology advancements leads to high accuracy and minimal invasive stents surgeries tends to provide opportunities for industrial growth. Followed by, rising coronary heart patients stimulates the demand for PCI procedure.

Stringent regulatory rules act as a barrier in the growth of stents market. For instance, European Association of Percutaneous Cardiovascular Interventions provides the clinical guidelines for the usage of stents. Moreover, Office of Combination Products also have set of guidelines for the use of drug eluting stents by medical professionals. These hinders the growth of the stents market across the globe.

Stent Market

The Global Stents Market Segmentation:

By Type

  • Bare-metal Stents
  •  Bioresorbable Vascular Scaffold
  • Drug-Eluting

By Mode of delivery

  • Self-expandable
  • Balloon Expandable

By Materials

  • Metal
    •  Stainless Steel
    •  Nitinol
    •  CoCr
  •  Polymer

 By End-User

  • Hospital
  • Ambulatory Surgery Centers
  • Others

 By Geographical Region

  • North America
  • Europe
  • Asia- Pacific
  • Latin America
  • Middle East & Africa

Based on type, drug- eluting stents is expected to boost the stents market during the forecast period

Drug-eluting stents can be used for various treatments like renal diseases, ST-segment elevation myocardial infraction (STEMI), diabetes etc. Technology advancements boost the growth of drug-eluting stents market. These stents are coated with medicine, which get released in vessels and tends to expand the vessels and prevents the blockages in future.  This leads to elevate the demand for the growth of stents market.

Based on mode of delivery, self-expandable stents delivery is expected to dominate the stents market in the forecast period

Self–expandable stents segment to hold maximum share during the forecast period. Clinically proven efficiency of self-expandable stents creates an opportunity for increase in players for manufacturing across the globe. Self-expandable stents prove to be feasible in the treatment of acute myocardial infraction and owns the ability of enlargement of artery at perfect position.  This feature of self-expandable stents will drive the growth of the stents market during the forecast period.

Based on materials, metallic segment registered the highest share in 2020 and expected to increase the market share of stents in coming years

The metal segment is expected to increase the market share of stents market. Metallic stents are considered to the material of choice, as it offers many advantages over other materials like texture, flexibility, biocompatibility and fracture. Another factor for propelling the growth of metallic stent segments is the metallic stents with biodegradable polymers.

Based on end user, hospital segment is expected to hold major market share in coming years

Hospital segment to dominate the tents market in coming years. Hospitals provides each and every facility needed for surgeries and are well equipped. The external factors like consumption of alcohol, smoking, change in life styles adds in populations which leads to increase in number hospital admissions. This stimulates the need for advanced treatments and offers growth opportunity of the stents market. Also, the presence of skilled doctors and medical staff and quality of care offered after surgeries, supports the growth of this segment.

Based on geographical region, North America held the largest share in 2020.

North America is considered to be leading region in stents market as compared to other regions. Factors like life style, diseased conditions, obesity, incidences of stroke, heart attack are driving the growth of stents market in North America. Provided, the use of advanced technology further supports in increase in stents market revenue. Increase in number of various diseases like PCI, coronary heart diseases, angioplasty leads to usage of stents in such procedures and stimulate the market of North America.

Asia Pacific is expected to witness the fastest growth during the forecast period. Presence of government reforms and economic developments with in developing countries like India and China, acts as supporting factor for the regional growth of stents market. Adaption of western culture, and sedentary lifestyle contribute to the growth of market.

Company Profiles and Competitive Intelligence: Medtronic plc, Biotronik SE & co. KG, Abbott laboratories, Boston scientific corporation, Microport scientific corporation, Biosensors international group, ltd., B. Braun Melsungen AG, Terumo corporation, Stentys SA, Meril life sciences pvt. Ltd., Vascular concepts, and Translumina GmbH are some of the major operating players in the global stent industry.

The report also provides in-depth analysis of stents market dynamics such as drivers, restraints opportunities and challenges

Drivers

  • Advancements in technology and increase in demand for new products
  • Increase in incidence of coronary artery disease and subsequent growth in the number of minimal invasive surgeries
  • Rising geriatric population, diabetic population and heart related health diseases.

Restraints

  • Stringent regulatory rules for approval of products and presence of alternative treatment for artery disease.  
  • Product failure and product recalls by companies
  • Side effects associated with the use of coronary stents

Opportunities

  • Demand for bioresorbable vascular scaffolds
  • Demand for the growth in untapped stents market in developed countries

Challenges

  • Complications and side effects associated with stents
  • Need for highly skilled surgeons and lack of availability of equipment in developing and under developed countries in terms of economy.

COVID-19 Impact on the Stents Market Analysis

Covid-19 has highly affected the industries in terms of growth, economy, health and mental wellbeing of every individual. In this challenging situation, healthcare industry is trying to give best services in terms of quality and safety.  Due to sudden outbreak of covid-19, there was decline in growth of stents market. The supply of raw materials, medical devices, equipment were delayed due to restrictions on movements. For instance, the manufacturing plants in the US, Ireland and Malaysia to supply the products across the globe was impacted. Due to decrease in demand for coronary stents, the products related to surgeries and stents were not sold and this affected the growth of stents market. Whereas, the subsidiary companies without proper manufacturing unit's tires to import the stents with relative higher cost and overall cost of procedures in selected regions to the patients. During covid pandemic, the focus of medical practitioner was on providing treatment to covid patients, which led to delay in performing surgeries.

The report also provides in-depth analysis of key trends in the stents market

Sr. No.

Trends

Impact

1

Due to Covid-19, there has been decline in the demand for the surgical procedures and medical devices due to lack in supply of materials from manufacturing countries.

Negative

2

Increasing number of coronary artery disease and peripheral vascular disorders globally, tends to increase in demand for stents.

Positive

The report also provides an in-depth analysis of recent news developments and investments

  • In July 2020, Endologix recalled abdominal stent graft system due to material weakness during the manufacturing process. This was leading to polymer leaks during the implantation of stent graft system.  
  • In July 2020, Sahajanand Medical Technologies one of the India’s largest cardiac stent makers, plans to sell a 30% stake for about $100-150 million to support its clinical trials in the US.

Company Profiles and Competitive Intelligence

The key players operating in the stents market are:

  • Medtronic plc
  •  Abbott laboratories
  •  Boston scientific corporation
  •  Biosensors international group, ltd.
  •  Biotronik se & co. Kg
  •  B. Braun melsungen ag
  •  Terumo corporation
  • Stentys sa
  •  Microport scientific corporation
  •  Meril life sciences pvt. Ltd.
  •  Vascular concepts
  • Translumina gmbh

The unique insights provided by this report also includes the following:

  • In-depth value chain analysis
  • Opportunity mapping
  • Sector snapshot
  • Key Players Positioning Matrix
  • Regulatory scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market trends
  • Covid-19 impact analysis
  • Product comparison
  • Pre & Post COVID 19 impacts on stents market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global stents market was valued at US $ 8.0 Bn in 2020 and is anticipated to reach US$ 11.3 Bn by 2027

The stents market is estimated to grow at a compound annual growth rate (CAGR) of 4.9% during 2020-2027

In the base year 2020, North America accounted for more than 25.0% share in the stents market

Few key players include, but not limit up to: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo corporation, stentys SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, and Translumina GmbH

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1. Introduction
    1. Product Outline
    2. What are stents
    3. Different types of Stents
    4. Analysis of Stents
    5. Supply Chain Analysis
    6. Covid -19 Impact
    7. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    8. Technology Overview
  2. Regulatory Landscape for stents 
    1. Regulations and Standards
  3. Stents Market Pricing Analysis
    1. Prices of Stents
  4. Stents Market by Type
    1. Bare-metal Stents
    2. Bioresorbable Vascular Scaffold
    3. Drug Eluting Stents
  5. Stents Market by Mode of Delivery
    1. Self-expandable Stents
    2. Balloon Expandable Stents
  6. Stents Market by Materials
    1. Metal
      1. Stainless Steel
      2. Nitinol
      3. CoCr
    2. Polymer & Co-polymer
  7. Stents Market by End user
    1. Hospital
    2. Ambulatory Surgery Centers
    3. Others
  8. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Netherlands
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Middle East and Africa
    5. South America
  9. Key Strategic Insights
  10. New Raw Material Sources
    1. New Applications
    2. Emerging Technologies
    3. Opportunity mapping
    4. Critical Success Factors
    5. Environmental Impact and sustainability issues
    6. Consumer preferences
  11. Key Market Trends / Recent Developments
  12. Competitive Scenario
    1.  Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product launches
    5. Ranking of Key Players
  13. Key Global Players
    1. Medtronic Plc
    2.  Abbott Laboratories
    3.  Boston Scientific Corporation
    4.  Biosensors International Group, ltd.
    5.  Biotronik se & Co. KG
    6.  B. Braun Melsungen AG
    7.  Terumo Corporation
    8. Stentys SA
    9.  Microport Scientific Corporation
    10.  Meril life sciences Pvt. Ltd.
    11.  Vascular Concepts
    12. Translumina GmbH  

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization